CarvalhoC.A.. Acquired platelet dysfunction in patients with uremia.Hematology/Oncology Clinics of North America1990; 4: 129–3.
2.
WeissH.J., TurittoV.T., BaumgartnerH.R.. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood: shear rate - dependent decrease of adhesion in von Willebrand disease and the Bernard - Soulier Syndrome.J Lab Clin Med1978; 92: 750–64.
3.
SteinerR.W., CogginsC., CarvalhoC.A.. Bleeding time in uremia: a useful test to assess clinical bleeding.Am J Hematol1979; 7: 107–17.
4.
FernandezF., GoudableC., SieP.. Low hematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions.Br J Haematol1985; 59: 139–48.
5.
AkizawaT., KinugasaE., KiiaokaT., KoshitawaS.. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.Nephron1991; 58: 400–6.
6.
GawazM.P., DobosG., SpathM.. Impaired function of platelet membrane glycoprotein IIb IIIa in end stage renal disease.J Am Soc Nephrol1994; 5: 36–46.
7.
SloandJ.A., SloandE.M.. Platelet function and bleeding time in uremia: relationship to hemodialysis. In submittal to J Am Soc Nephrol.
8.
JansonP.A., JubelirerS.J., WeinsteinM.S., DeykinD.. Treatment of bleeding tendency in uremia with cryoprecipitate.N Engl Med1980; 303: 1318–22.
9.
SloandE.M., KesslerC.M., SloandJ.A.. DDVAP corrects the platelet dysfunction produced by cardiopulmonary bypass, hemodialysis, and prolonged storage: Re-expression of GPIb on the platelet membrane.Desmopressin in Bleeding Dis.New York: Plenum Press1993; 147–54.
10.
ViganoG., GaspariF., LocatelliM., PusineriF., BonatiM., RemuzziG.. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia.Kidney Int1988; 34: 853–8.
11.
ViganoG., ZojaC., CornaD.. 17B-estradiol is the most active component of the conjugated estrogen mixture on uremic bleeding by a receptor mechanism.J Pharm Exp Ther1990; 252: 344–8.
12.
ZoyaC., NorisM., CornaD.. L-Arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia.Lab Invest1991; 65: 479–83.
SloandJ.A., SchiffM.J.. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia.Am J Kid Dis1995; 26: 22–6.
15.
LaffertyF.W., FiskeM.E.. Postmenopausal estrogen replacement: A long term cohort study.Am J Med1994; 97: 66–77.
